Key Statistics
Market Cap$175.76M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.48
52W High$7.13
52W Low$1.21
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees15
Price Performance
1 Week-0.37%
3 Month-31.19%
1 Year+108.59%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$28.20M
Liabilities$88.44M
Net Income$41.07M loss
About
Galectin Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of therapies for fibrotic, cancerous and other diseases. The company is headquartered in Norcross, Georgia.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze GALT with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.